News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
660,806 Results
Type
Article (53546)
Company Profile (435)
Press Release (606808)
Multimedia
Podcasts (154)
Webinars (19)
Section
Business (167556)
Career Advice (3111)
Deals (30549)
Drug Delivery (120)
Drug Development (80385)
Employer Resources (177)
FDA (15524)
Job Trends (13465)
News (299855)
Policy (29403)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2856)
Academic (1)
Accelerated approval (32)
Adcomms (36)
Allergies (141)
Alliances (44875)
ALS (176)
Alzheimer's disease (1743)
Antibody-drug conjugate (ADC) (335)
Approvals (15728)
Artificial intelligence (538)
Autoimmune disease (166)
Automation (34)
Bankruptcy (296)
Best Places to Work (11034)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (308)
Bladder cancer (158)
Brain cancer (63)
Breast cancer (656)
Cancer (4927)
Cardiovascular disease (427)
Career advice (2644)
Career pathing (39)
CAR-T (310)
CDC (46)
Celiac Disease (2)
Cell therapy (832)
Cervical cancer (37)
Clinical research (68343)
Collaboration (1777)
Company closure (5)
Compensation (1114)
Complete response letters (69)
COVID-19 (2750)
CRISPR (98)
C-suite (820)
Cystic fibrosis (155)
Data (6263)
Decentralized trials (2)
Denatured (47)
Depression (146)
Diabetes (515)
Diagnostics (6076)
Digital health (44)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (272)
Drug pricing (192)
Drug shortages (32)
Duchenne muscular dystrophy (244)
Earnings (65449)
Editorial (65)
Employer branding (21)
Employer resources (159)
Events (112302)
Executive appointments (928)
FDA (18597)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1520)
Gene editing (215)
Generative AI (49)
Gene therapy (679)
GLP-1 (1031)
Government (4702)
Grass and pollen (7)
Guidances (354)
Healthcare (18518)
HIV (60)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (277)
Immuno-oncology (62)
Indications (102)
Infectious disease (3013)
Inflammatory bowel disease (203)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (244)
Interviews (604)
IPO (14844)
IRA (54)
Job creations (2812)
Job search strategy (2141)
JPM (68)
Kidney cancer (14)
Labor market (80)
Layoffs (540)
Leadership (39)
Legal (6165)
Liver cancer (88)
Longevity (15)
Lung cancer (662)
Lymphoma (380)
Machine learning (41)
Management (63)
Manufacturing (798)
MASH (171)
Medical device (12270)
Medtech (12318)
Mergers & acquisitions (16806)
Metabolic disorders (1335)
Multiple sclerosis (161)
NASH (21)
Neurodegenerative disease (345)
Neuropsychiatric disorders (99)
Neuroscience (3039)
Neurotech (1)
NextGen: Class of 2026 (6401)
Non-profit (4534)
Now hiring (48)
Obesity (636)
Opinion (324)
Ovarian cancer (167)
Pain (212)
Pancreatic cancer (219)
Parkinson's disease (293)
Partnered (34)
Patents (483)
Patient recruitment (492)
Peanut (57)
People (51490)
Pharmaceutical (77)
Pharmacy benefit managers (29)
Phase 1 (21539)
Phase 2 (30217)
Phase 3 (22422)
Pipeline (5119)
Policy (313)
Postmarket research (2362)
Preclinical (9221)
Press Release (68)
Prostate cancer (249)
Psychedelics (55)
Radiopharmaceuticals (299)
Rare diseases (919)
Real estate (5178)
Recruiting (75)
Regulatory (23004)
Reports (40)
Research institute (2597)
Resumes & cover letters (499)
Rett syndrome (28)
RNA editing (21)
RSV (73)
Schizophrenia (157)
Series A (253)
Series B (199)
Service/supplier (9)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (165)
Sponsored (46)
Startups (3365)
State (2)
Stomach cancer (19)
Supply chain (103)
Tariffs (83)
The Weekly (106)
Vaccines (996)
Venture capital (96)
Weight loss (425)
Women's health (79)
Worklife (22)
Date
Today (115)
Last 7 days (601)
Last 30 days (2113)
Last 365 days (30199)
2026 (2999)
2025 (30507)
2024 (35011)
2023 (39220)
2022 (49533)
2021 (53890)
2020 (51712)
2019 (44648)
2018 (33780)
2017 (31224)
2016 (30771)
2015 (35416)
2014 (27655)
2013 (22739)
2012 (24008)
2011 (24486)
2010 (22312)
Location
Africa (896)
Alabama (86)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (39097)
Australia (6974)
California (10934)
Canada (3171)
China (1136)
Colorado (455)
Connecticut (459)
Delaware (325)
Europe (90570)
Florida (1610)
Georgia (339)
Hawaii (3)
Idaho (54)
Illinois (842)
India (67)
Indiana (470)
Iowa (20)
Japan (419)
Kansas (123)
Kentucky (39)
Louisiana (27)
Maine (61)
Maryland (1311)
Massachusetts (8185)
Michigan (300)
Minnesota (600)
Mississippi (4)
Missouri (126)
Montana (32)
Nebraska (22)
Nevada (108)
New Hampshire (76)
New Jersey (2944)
New Mexico (32)
New York (2947)
North Carolina (1466)
North Dakota (9)
Northern California (5305)
Ohio (324)
Oklahoma (22)
Oregon (40)
Pennsylvania (2218)
Puerto Rico (20)
Rhode Island (45)
South America (1174)
South Carolina (60)
Southern California (4263)
Tennessee (140)
Texas (1666)
United States (39100)
Utah (302)
Vermont (1)
Virginia (253)
Washington D.C. (77)
Washington State (933)
West Virginia (4)
Wisconsin (106)
Wyoming (1)
660,806 Results for "the james hutton institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Levicept Announces the Appointment of James Sandy as Chief Development Officer
February 4, 2026
·
3 min read
Pharm Country
Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Hoth Therapeutics, Inc. is scheduled to attend the EF Hutton Annual Global Conference in New York, NY.
May 1, 2024
·
1 min read
Press Releases
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
January 13, 2026
·
4 min read
Biotech Beach
ChemDiv to Participate in the EF Hutton Annual Global Conference, May 15, 2024
ChemDiv, Inc, announced that Bill Farley, CEO, will participate in the EF Hutton Annual Global Conference.
May 13, 2024
·
1 min read
Press Releases
Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
November 27, 2025
·
5 min read
Press Releases
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors
Expanding U.S. market access with an experienced technology investor and AI-driven growth strategist
January 2, 2026
·
3 min read
Pharm Country
Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference
Sonnet BioTherapeutics Holdings, Inc., a biopharmaceutical company developing innovative targeted biologic drugs, will be participating in the EF Hutton Annual Global Conference, which will take place on May 15, 2024 at The Plaza Hotel in New York.
May 6, 2024
·
2 min read
BioCapital
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
Processa Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, announced that management will be participating in the EF Hutton Annual Global Conference being held May 15, 2024 at The Plaza Hotel in New York City.
May 6, 2024
·
2 min read
Press Releases
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
January 8, 2026
·
11 min read
Press Releases
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
September 25, 2025
·
5 min read
1 of 66,081
Next
